Search research articles
Contact Us
Filters
Showing results (201-210 of 289) with videos related to
Page
of 29
Sort By:
Clinical Lung Cancer
|
March 19, 2020
Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial
David E Gerber, Heidi A Hamann, Claudia Chavez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 15, 2024
Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations
Sheena Bhalla, Vijaya Natchimuthu, Jessica L Lee, et al.
Oncology
|
December 18, 2019
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer
Ruth Sacks, Jennie Y Law, Hong Zhu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A novel and potent MICA/B antibody is therapeutically effective in <i>KRAS LKB1</i> mutant lung cancer models
Ryan R Kowash, Manoj Sabnani, Laura T Gray, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 11, 2025
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research Physicians
David E Gerber, Nikhil I Khushalani, Ang Gao, et al.
Cancer Medicine
|
August 2, 2025
Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials
Sukh Makhnoon, Fabian Robles, Jessica L Lee, et al.
Journal of Surgical Oncology
|
March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report
Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
David E Gerber, David A Boothman, Farjana J Fattah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
Ramaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 289) with videos related to
Sort By:
Page
of 29
Clinical Lung Cancer
|
March 19, 2020
Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial
David E Gerber, Heidi A Hamann, Claudia Chavez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 15, 2024
Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations
Sheena Bhalla, Vijaya Natchimuthu, Jessica L Lee, et al.
Oncology
|
December 18, 2019
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer
Ruth Sacks, Jennie Y Law, Hong Zhu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A novel and potent MICA/B antibody is therapeutically effective in <i>KRAS LKB1</i> mutant lung cancer models
Ryan R Kowash, Manoj Sabnani, Laura T Gray, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 11, 2025
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research Physicians
David E Gerber, Nikhil I Khushalani, Ang Gao, et al.
Cancer Medicine
|
August 2, 2025
Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials
Sukh Makhnoon, Fabian Robles, Jessica L Lee, et al.
Journal of Surgical Oncology
|
March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report
Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
David E Gerber, David A Boothman, Farjana J Fattah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
Ramaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.
Page
of 29